Do triglyceride and low-density lipoprotein blood levels affect the vascular response to cyclosporine?
Carrier
M
M
Department of Surgery, Montreal Heart Institute, Quebec, Canada.
Thai
P
P
Stewart
D
D
Pelletier
L C
LC
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D016572:Cyclosporine / Q000097:blood / Q000494:pharmacology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D016232:Endothelins / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology; D006614:Hindlimb / Q000098:blood supply; D008077:Lipoproteins, LDL / Q000097:blood*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D005996:Nitroglycerin / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D012077:Renal Artery / Q000187:drug effects / Q000502:physiology*; D014280:Triglycerides / Q000097:blood*; D014664:Vasodilation / Q000187:drug effects
D016232:Endothelins; D008077:Lipoproteins, LDL; D014280:Triglycerides; D016572:Cyclosporine; D005996:Nitroglycerin; D000109:Acetylcholine; D009638:Norepinephrine